Discovery of potential targets of selenomethionine-mediated chemoprevention in colorectal carcinoma mouse model using proteomics analysis

Carcinogenesis

Volumn 34, Issue 7, 2013, Pages 1575-1584

  Rahman, Md Mujibur ^a,b   Seo, Young Rok ^a,b  

^a Dongguk University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; C REACTIVE PROTEIN; LIPOCORTIN 2; PROHIBITIN; PURINE NUCLEOSIDE PHOSPHORYLASE; SELENOMETHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CHRONIC INFLAMMATION; COLON; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIET SUPPLEMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; ION TRAP MASS SPECTROMETRY; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; APOPTOSIS; AZOXYMETHANE; C-REACTIVE PROTEIN; CHEMOPREVENTION; COLONIC POLYPS; COLORECTAL NEOPLASMS; DEOXYGUANOSINE; DEXTRAN SULFATE; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED ICR; NEOPLASM PROTEINS; OXIDATIVE STRESS; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; REPRESSOR PROTEINS; SELENOMETHIONINE; SOFTWARE; TUMOR MARKERS, BIOLOGICAL;

EID: 84880319728     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt078     Document Type: Article

References (57)

1. Jemal, A. et al. (2011) Global cancer statistics. CA. Cancer J. Clin., 61, 69-90.
2. Center, M.M. et al. (2009) International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prev., 18, 1688-1694.
3. Ferlay, J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
4. Triantafillidis, J.K. et al. (2009) Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res., 29, 2727-2737.
5. Tinggi, U. (2008) Selenium: its role as antioxidant in human health. Environ. Health Prev. Med., 13, 102-108.
6. Brigelius-Flohé,R. (2008) Selenium compounds and selenoproteins in cancer. Chem. Biodivers., 5, 389-395.
7. Letavayová,L. et al. (2008) Toxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiae. Mutat. Res., 638, 1-10.
8. Nelson, M.A. et al. (2005) Studies into the anticancer effects of selenomethionine against human colon cancer. Ann. N. Y. Acad. Sci., 1059, 26-32.
9. Lü,J. et al. (2005) Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells. Antioxid. Redox Signal., 7, 1715-1727.
10. Marshall, J.R. (2008) Prevention of colorectal cancer: diet, chemoprevention, and lifestyle. Gastroenterol. Clin. North Am., 37, 73-82
11. Valdiglesias, V. et al. (2010) In vitro evaluation of selenium genotoxic, cytotoxic, and protective effects: a review. Arch. Toxicol., 84, 337-351.
12. Qiao, Y.L. et al. (2009) Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J. Natl. Cancer Inst., 101, 507-518.
13. Lippman, S.M. et al.(2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 301, 39-51.
14. Herszényi, L. et al. (2008) Chemoprevention of colorectal cancer: feasibility in everyday practice? Eur. J. Cancer Prev., 17, 502-514.
15. Brozmanová,J. et al. (2010) Selenium: a double-edged sword for defense and offence in cancer. Arch. Toxicol., 84, 919-938.
16. Baines, A.T. et al. (2000) The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts. Cancer Lett., 160, 193-198.
17. Tanaka, T. et al. (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci., 94, 965-973.
18. Krehl, S. et al. (2012) Glutathione peroxidase-2 and selenium decreased inflammation and tumors in a mouse model of inflammation-associated carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcinogenesis, 33, 6
19. Suzuki, R. et al. (2006) Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis, 27, 162-169.
20. Yan, L. et al. (1999) Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice. Anticancer Res., 191337-1342.
21. Nikitin, A. et al. (2003) Pathway studio-the analysis and navigation of molecular networks. Bioinformatics, 19, 2155-2157.
22. Charafe-Jauffret, E. et al. (2004) Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'. J. Pathol., 202, 265-273.
23. Simons, B.D. et al. (1992) Relationship of polyps to cancer of the large intestine. J. Natl. Cancer Inst., 84, 962-966.
24. Kim, M. et al. (2009) Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. Int. J. Cancer, 124, 264-271.
25. Chambers, A.F. et al. (2002) Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer, 2, 563-572.
26. Varghese, H.J. et al. (2002) Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. Cancer Res., 62, 887-891.
27. Jao, S.W. et al. (1996) Effect of selenium on 1,2-dimethylhydrazineinduced intestinal cancer in rats. Dis. Colon Rectum, 39, 628-631.
28. Suzana, S. et al. (2009) Relationship between selenium and breast cancer: a case-control study in the Klang Valley. Singapore Med. J., 50, 265-269.
29. Chiang, E.C. et al. (2009) Defining the optimal selenium dose for prostate cancer risk reduction: insights from the u-shaped relationship between selenium status, DNA damage, and apoptosis. DoseResponse., 8, 285-300.
30. Whanger, P.D. (2004) Selenium and its relationship to cancer: an update. Br. J. Nutr., 91, 11-28.
31. Stewart, M.S. et al. (1999) Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic. Biol. Med., 26, 42-48.
32. Suryo Rahmanto, A. et al. (2011) Catalytic activity of selenomethionine in removing amino acid, peptide, and protein hydroperoxides. Free Radic. Biol. Med., 51, 2288-2299.
33. Kim, J.H. et al. (2011) Effects of selenium on colon carcinogenesis induced by azoxymethane and dextran sodium sulfate in mouse model with highiron diet. Lab. Anim. Res., 27, 9-18.
34. Bhattacharya, A. et al. (2011) Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer. Anticancer Res., 31, 387-393.
35. Kondo, S. et al. (2000) Overexpression of the hOGG1 gene and high 8-hydroxy-2'-deoxyguanosine (8-OHdG) lyase activity in human colorectal carcinoma: regulation mechanism of the 8-OHdG level in DNA. Clin. Cancer Res., 6, 1394-1400.
36. Seo, Y.R. et al. (2002) Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene, 21, 3663-3669.
37. Yeo, M. et al. (2010) Loss of SM22 is a characteristic signature of colon carcinogenesis and its restoration suppresses colon tumorigenicity in vivo and in vitro. Cancer, 116, 2581-2589.
38. Nadiminty, N. et al. (2008) Mechanisms of selenium chemoprevention and therapy in prostate cancer. Mol. Nutr. Food Res., 52, 1247-1260.
39. Theiss, A.L. et al. (2011) The role and therapeutic potential of prohibitin in disease. Biochim. Biophys. Acta, 1813, 1137-1143.
40. Kang, X. et al. (2008) Prohibitin: a potential biomarker for tissue-based detection of gastric cancer. J. Gastroenterol., 43, 618-625.
41. Roessler, M. et al. (2005) Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin. Cancer Res., 11, 6550-6557.
42. Sanfilippo, O. et al. (1994) Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma. Cancer Biochem. Biophys., 14, 57-66.
43. Roberts, E.L. et al. (2004) Plasma purine nucleoside phosphorylase in cancer patients. Clin. Chim. Acta, 344, 109-114.
44. Saini, P. et al. (2009) Hypusine-containing protein eIF5A promotes translation elongation. Nature, 459, 118-121.
45. Li, A.L. et al. (2004) A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J. Biol. Chem., 279, 49251-49258.
46. Seo, Y.R. et al. (2002) Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc. Natl. Acad. Sci. U.S.A., 99, 14548-14553.
47. Mussunoor, S. et al. (2008) The role of annexins in tumour development and progression. J. Pathol., 216, 131-140.
48. Duncan, R. et al. (2008) Characterisation and protein expression profiling of annexins in colorectal cancer. Br. J. Cancer, 98, 426-433.
49. Emoto, K. et al. (2001) Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer, 92, 1419-1426.
50. Johnson, T.V. et al. (2010) C-reactive protein as a clinically useful biomarker of metastasis of renal cell carcinoma. Mol. Diagn. Ther., 14, 191-193.
51. Eisenhardt, S.U. et al. (2009) C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle, 8, 3885-3892.
52. Estornes, Y. et al. (2007) Differential involvement of destrin and cofilin-1 in the control of invasive properties of Isreco1 human colon cancer cells. Int. J. Cancer, 121, 2162-2171.
53. Rho, J.H. et al. (2008) Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer. J. Proteome Res., 7, 2959-2972.
54. Kisucka, J. et al. (2008) Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ. Res., 103, 598-605.
55. Volp, A.C.P. et al. (2010) Selenium antioxidant effects and its link with inflammation and metabolic syndrome. Rev. Nutr., 23, 581-590.
56. Walston, J. et al. (2006) Serum antioxidants, inflammation, and total mortality in older women. Am. J. Epidemiol., 163, 18-26.
57. Hertz, N. et al. (2009) Improved survival in patients with end-stage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study. J. Int. Med. Res., 37, 1961-1971.